Experiment: 2KLX

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N TOCSY	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
2	3D 1H-15N NOESY	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
3	2D 1H-15N HSQC	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
4	2D 1H-13C HSQC	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
5	3D HNCO	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
6	3D HNCA	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
7	3D HN(CO)CA	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
8	3D CBCA(CO)NH	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
9	3D HNCACB	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298
10	3D 1H-13C NOESY	0.5 mM [U-100% 15N] protein, 100 mM potassium phosphate, 10 mM potassium chloride, 8 % D2O	90% H2O/10% D2O	110	7	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	600
3	Bruker	AVANCE	750

NMR Refinement
Method	Details	Software
torsion angle dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	Sparky		CCPN
4	collection	TopSpin		Bruker Biospin
5	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.